Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.
Two peptides increase inflammation-related protein production in prostate and prostate cancer cells
AI simplified
Abstract
VIP stimulated the production of interleukin-6 (IL-6) in DU-145/AR prostate cancer and normal prostate epithelial cells.
- VPAC1, VPAC2, and PAC1 receptor mRNAs were present in both prostate cancer cells and normal prostate epithelial cells.
- PACAP also increased IL-6 production in normal prostate epithelial cells.
- VIP enhanced IL-6 promoter transcriptional activity specifically in DU-145/AR prostate cancer cells.
- VIP and PACAP may influence IL-6 production in normal and cancerous prostate cells.
AI simplified